A pilot study of adjuvant chemotherapy with carboplatin and oral S‐1 for patients with completely resected stage II to IIIA non‐small cell lung cancer

BACKGROUND: Adjuvant chemotherapy with platinum‐based regimens for completely resected early‐stage non‐small cell lung cancer (NSCLC) provides overall survival benefit in several clinical trials. OBJECTIVES: We conducted this prospective study to evaluate the efficacy and safety of adjuvant chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hisashi, Tabe, Chiori, Okumura, Fumihiko, Shiratori, Toshihiro, Ishioka, Yoshiko, Itoga, Masamichi, Taima, Kageaki, Morimoto, Takeshi, Kimura, Daisuke, Tsushima, Takao, Tasaka, Sadatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262903/
https://www.ncbi.nlm.nih.gov/pubmed/32351044
http://dx.doi.org/10.1111/1759-7714.13444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262903/
https://www.ncbi.nlm.nih.gov/pubmed/32351044
http://dx.doi.org/10.1111/1759-7714.13444

Ejemplares similares